title: Reply to Matonti et al.
authors.forename: G
authors.initials: G
authors.lastname: Querques
authors.forename: M
authors.initials: M
authors.lastname: Codenotti
authors.forename: G
authors.initials: G
authors.lastname: Maestranzi
authors.forename: U
authors.initials: U
authors.lastname: De Benedetto
authors.forename: F
authors.initials: F
authors.lastname: Bandello
mesh_terms: D005260:Female; D005341:Fibrinolysin / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D012163:Retinal Detachment / Q000188:drug therapy*; D020255:Vitreous Detachment / Q000188:drug therapy*
chemical_list: D005343:Fibrinolytic Agents; D005341:Fibrinolysin